|
⚲
|
| Keyboard |
| Foresite Capital Fund IV LP
✚
|
|
|---|---|
| CIK # | 0001704131 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001704131] | |
| 4 | [0001704131] | |
| D | [0001704131] | |
| SC 13D | [0001704131] | |
| SC 13G | [0001704131] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 5,204,684 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-04 | Conversion | 10,000,000 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 2,502,252 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 1,340,878 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Buy | 55,555 | $18.00 | 999,990 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 37,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 229,428 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 697,885 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 37,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 1,626 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 67,207 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 458,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 348,942 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 37,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 922 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 38,133 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 408,725 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 335,521 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 3,048,192 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series C Preferred Stock · derivative
|
2026-02-04 | Conversion | 12,123 | $0.00 | |
| showing 20 of 83 most recent transactions | |||||